Related Experiment Video
Updated: Jun 5, 2026

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
Published on: September 7, 2021
The case for therapeutic proteostasis modulators.
The ubiquitin proteasome pathway (UPP) maintains cellular balance. Dysregulation of UPP contributes to diseases like neurodegeneration and cancer, requiring targeted therapeutic strategies.
Area of Science:
- Cellular Biology
- Biochemistry
- Molecular Medicine
Background:
- The ubiquitin proteasome pathway (UPP) is essential for eukaryotic cellular function and proteostasis.
- Alterations in UPP can result from environmental factors, aging, or genetic predispositions, leading to pathological conditions.
Discussion:
- Decreased proteasome activity impairs the clearance of misfolded or excess proteins, contributing to neurodegenerative and cardiac diseases.
- Conversely, increased proteasome activity is linked to conditions such as muscle wasting, sepsis, cachexia, and uremia.
- The role of UPP in disease pathogenesis is complex, with both reduced and enhanced activity having detrimental effects.
Key Insights:
- Selective inhibition of proteostasis is a promising therapeutic approach for misfolded protein disorders.
- Broad-spectrum proteasome inhibitors are utilized in cancer therapy, particularly for targeting tumor metastasis.
- Modulating or activating proteostasis mechanisms may offer therapeutic benefits for muscle wasting and neurodegenerative conditions.
Outlook:
- Further research into the precise mechanisms of UPP dysregulation is needed.
- Development of targeted therapies based on UPP modulation holds potential for treating a range of diseases.
- Understanding the dual role of UPP in disease offers new avenues for therapeutic intervention.
More Related Videos
12:38Using Caenorhabditis elegans as a Model System to Study Protein Homeostasis in a Multicellular Organism
Published on: December 18, 2013
07:22The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
Published on: January 12, 2024
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Regulation of the Unfolded Protein Response
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...